01 1Bristol Myers Squibb
02 1Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
03 1Meiji Seika Pharma
04 1Pierrel
05 1SHANGHAI ASIA PHARMACEUTICAL CO LTD
01 5KANAMYCIN SULFATE
01 2China
02 1Italy
03 1Japan
04 1U.S.A
01 1Active
02 4Inactive
01 1Complete
02 4Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13325
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-11-30
Pay. Date : 2016-03-08
DMF Number : 28275
Submission : 2014-05-06
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13392
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13599
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13628
Submission : 1998-09-01
Status : Inactive
Type : II
59
PharmaCompass offers a list of Kanamycin Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Kanamycin Sulfate manufacturer or Kanamycin Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Kanamycin Sulfate manufacturer or Kanamycin Sulfate supplier.
PharmaCompass also assists you with knowing the Kanamycin Sulfate API Price utilized in the formulation of products. Kanamycin Sulfate API Price is not always fixed or binding as the Kanamycin Sulfate Price is obtained through a variety of data sources. The Kanamycin Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tox21_202817 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tox21_202817, including repackagers and relabelers. The FDA regulates Tox21_202817 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tox21_202817 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tox21_202817 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tox21_202817 supplier is an individual or a company that provides Tox21_202817 active pharmaceutical ingredient (API) or Tox21_202817 finished formulations upon request. The Tox21_202817 suppliers may include Tox21_202817 API manufacturers, exporters, distributors and traders.
click here to find a list of Tox21_202817 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tox21_202817 DMF (Drug Master File) is a document detailing the whole manufacturing process of Tox21_202817 active pharmaceutical ingredient (API) in detail. Different forms of Tox21_202817 DMFs exist exist since differing nations have different regulations, such as Tox21_202817 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tox21_202817 DMF submitted to regulatory agencies in the US is known as a USDMF. Tox21_202817 USDMF includes data on Tox21_202817's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tox21_202817 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tox21_202817 suppliers with USDMF on PharmaCompass.
We have 5 companies offering Tox21_202817
Get in contact with the supplier of your choice:
